Methods of treating or preventing emesis using growth hormone secretagogues

Details for Australian Patent Application No. 2008236584 (hide)

Owner Helsinn Therapeutics (U.S.), Inc.

Inventors Mann, William R.; Polvino, William J.

Agent Spruson & Ferguson

Pub. Number AU-A-2008236584

PCT Pub. Number WO2008/124183

Priority 60/922,742 10.04.07 US

Filing date 10 April 2008

Wipo publication date 16 October 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07D 213/00 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/124183 Priority application(s): WO2008/124183

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008236590-Dehazing a lubes product by integrating an air separation unit with the dehazing process

2008236580-Wagering game machine providing a write once run anywhere environment